Cargando…
Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects
Glioma‐initiating cells, which comprise a heterogeneous population of glioblastomas, contribute to resistance against aggressive chemoradiotherapy. Using drug reposition, we investigated a therapeutic drug for glioma‐initiating cells. Drug screening was undertaken to select candidate agents that inh...
Autores principales: | Tamai, Sho, Ichinose, Toshiya, Jiapaer, Shabierjiang, Hirai, Nozomi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Kobayashi, Masahiko, Hirao, Atsushi, Nakada, Mitsutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323113/ https://www.ncbi.nlm.nih.gov/pubmed/37142416 http://dx.doi.org/10.1111/cas.15827 |
Ejemplares similares
-
CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING
por: Tamai, Sho, et al.
Publicado: (2019) -
RBPJ contributes to the malignancy of glioblastoma and induction of proneural‐mesenchymal transition via IL‐6‐STAT3 pathway
por: Zhang, Guangtao, et al.
Publicado: (2020) -
Tumor Microenvironment in Glioma Invasion
por: Tamai, Sho, et al.
Publicado: (2022) -
Identification of antipsychotic drug fluspirilene as a potential anti-glioma stem cell drug
por: Dong, Yu, et al.
Publicado: (2017) -
Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p
por: Zhang, Jiakang, et al.
Publicado: (2020)